Inhibition of spinal microglial cathepsin S for the reversal of neuropathic pain
about
CX3CL1 is up-regulated in the rat hippocampus during memory-associated synaptic plasticityCXCL5 mediates UVB irradiation-induced painInterferon-gamma is a critical modulator of CB(2) cannabinoid receptor signaling during neuropathic painCrucial role of CB(2) cannabinoid receptor in the regulation of central immune responses during neuropathic painPathological and protective roles of glia in chronic painProinflammatory cytokines oppose opioid-induced acute and chronic analgesiaChemokines and the pathophysiology of neuropathic painMicroglia in the spinal cord and neuropathic painPain and Poppies: The Good, the Bad, and the Ugly of Opioid AnalgesicsOsteoarthritis joint pain: the cytokine connectionBrain-derived neurotrophic factor from microglia: a molecular substrate for neuropathic painChemokine-ligands/receptors: multiplayers in traumatic spinal cord injuryMicroglia centered pathogenesis in ALS: insights in cell interconnectivityCortical overexpression of neuronal calcium sensor-1 induces functional plasticity in spinal cord following unilateral pyramidal tract injury in ratEmerging targets in neuroinflammation-driven chronic painRedefining the concept of protease-activated receptors: cathepsin S evokes itch via activation of MrgprsCellular and Molecular Mechanisms of PainMAP kinase and pain.Stat3 inhibition attenuates mechanical allodynia through transcriptional regulation of chemokine expression in spinal astrocytes.Differential expression of Cathepsin S and X in the spinal cord of a rat neuropathic pain modelProteomic analysis uncovers novel actions of the neurosecretory protein VGF in nociceptive processing.Targeting the Microglial Signaling Pathways: New Insights in the Modulation of Neuropathic Pain.The human G93A-SOD1 mutation in a pre-symptomatic rat model of amyotrophic lateral sclerosis increases the vulnerability to a mild spinal cord compressionInteractions between chemokines: regulation of fractalkine/CX3CL1 homeostasis by SDF/CXCL12 in cortical neurons.Neuregulin-ErbB signaling promotes microglial proliferation and chemotaxis contributing to microgliosis and pain after peripheral nerve injury.Pain regulation by non-neuronal cells and inflammation.Spinal inhibition of p38 MAP kinase reduces inflammatory and neuropathic pain in male but not female mice: Sex-dependent microglial signaling in the spinal cord.Nerve injury evoked loss of latexin expression in spinal cord neurons contributes to the development of neuropathic painPathological pain and the neuroimmune interface.Connexin-43 induces chemokine release from spinal cord astrocytes to maintain late-phase neuropathic pain in mice.Neurobiology of microglial action in CNS injuries: receptor-mediated signaling mechanisms and functional rolesIRF8 is a critical transcription factor for transforming microglia into a reactive phenotypeCNS-infiltrating CD4+ T lymphocytes contribute to murine spinal nerve transection-induced neuropathic pain.Role of fractalkine/CX3CR1 interaction in light-induced photoreceptor degeneration through regulating retinal microglial activation and migrationMedication-overuse headache and opioid-induced hyperalgesia: A review of mechanisms, a neuroimmune hypothesis and a novel approach to treatment.Involvement of EphB1 receptors signalling in models of inflammatory and neuropathic pain.Interactions between the immune and nervous systems in pain.Enhanced neuroinflammation and pain hypersensitivity after peripheral nerve injury in rats expressing mutated superoxide dismutase 1.Microglial/macrophage GRK2 determines duration of peripheral IL-1beta-induced hyperalgesia: contribution of spinal cord CX3CR1, p38 and IL-1 signaling.Cysteinyl cathepsins and mast cell proteases in the pathogenesis and therapeutics of cardiovascular diseases.
P2860
Q21129473-E394EBBD-40E7-4E69-A7DF-6ED1F5205E63Q24631341-54ADBB43-E15D-481A-A0FC-734182DB4C7AQ24634125-48BC5E6A-A0D7-4E43-8576-A42FF69F3E29Q24634161-8EBC7560-F4CA-457E-906B-2BF8CB93EBE0Q24646738-F4429601-D346-42DD-871B-B19B34007EA3Q24650758-E7E14A2E-0B4B-411A-A069-3749E233FF96Q24683873-59AB59AA-6DED-4A49-BF84-39B8340CBD63Q26774353-0D01A938-6618-46C3-A3CB-7AFF377F9C77Q26782928-73D24889-45A6-443E-B960-329D59231A25Q26859004-197BDAAE-9568-4E36-BFCF-34A2B4CF7386Q26995375-AE7342EE-888D-4C18-8B2A-C59C201A2DA3Q27000469-B7F48B94-A005-42F4-8D7A-8BF844A4E426Q27009559-83DE744F-AE70-4C5D-9479-7C584889B707Q27324189-782D74B2-BCFA-47E8-91BD-21D1AC154A53Q28242435-DE998210-C1E8-4015-9F7F-FF54C73206FAQ28265606-48E0F67E-D950-462E-931D-3EA1AD402886Q29011961-60487DFD-2B6F-4C77-9300-98AD16E66913Q30482277-0C2AF14F-3BFA-4FFF-9473-36E25244DB0FQ31140663-161D2C1A-7141-4875-A925-A4A13D0ECA38Q33359738-B8BC74D9-E193-4CBD-A5CF-8724B9908DB0Q33568693-CCCD550E-56A4-4238-9EEB-E00C1EC20831Q33668659-687319B2-08A4-4934-B1E3-3619CB39FCC3Q33747031-8CA58043-CC4E-441A-A390-04CC98F6CE91Q33796131-77C3F891-8718-4A0F-909A-B8C59444F2D8Q33822811-3F7C6C4D-58ED-41DC-A465-9FB2A9CF8C3CQ33846188-6B3E6DB1-0677-4D57-9C22-C7B347739754Q33885584-13338B99-7B2F-40C3-B6FC-2DA0158AD82DQ33900077-F48C7ABA-ACE6-4B4C-909B-2A84C4737CF6Q33925677-513F5037-81DF-499E-A912-110A3BBD79AFQ33937485-AC7C501D-9CE0-4BBC-BAA4-1E2B9D8B4AB4Q34002086-876D7A58-D4E7-499D-9DBF-08B90AD79654Q34154359-2ADC8624-C048-4DF7-90AF-2132DCB15B33Q34235603-71ED5720-FEA8-4395-9727-032351DFEB65Q34247267-1FBD8BBC-58F0-4DFE-9608-45FD59318266Q34311105-97DB041D-3DE4-4AA9-8DBC-2B88DF2C3DAFQ34558589-893C4441-D4BB-43AC-B372-A21D72261C99Q34799654-7800B031-390F-4171-976C-8597BE1F624EQ34961354-7E2EADC4-D1F2-4670-8463-4E8C15DF0BBDQ34997832-6F0ED197-478C-475F-A3BD-D74B6699EDE2Q35098737-F5F6D942-6B04-4F17-81E1-E59DF4ED2447
P2860
Inhibition of spinal microglial cathepsin S for the reversal of neuropathic pain
description
2007 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հունիսին հրատարակված գիտական հոդված
@hy
article publié dans les Procee ...... f the United States of America
@fr
artículu científicu espublizáu en 2007
@ast
im Juni 2007 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 2007/06/19)
@sk
vědecký článek publikovaný v roce 2007
@cs
wetenschappelijk artikel (gepubliceerd op 2007/06/19)
@nl
наукова стаття, опублікована в червні 2007
@uk
name
Inhibition of spinal microglial cathepsin S for the reversal of neuropathic pain
@ast
Inhibition of spinal microglial cathepsin S for the reversal of neuropathic pain
@en
Inhibition of spinal microglial cathepsin S for the reversal of neuropathic pain
@nl
type
label
Inhibition of spinal microglial cathepsin S for the reversal of neuropathic pain
@ast
Inhibition of spinal microglial cathepsin S for the reversal of neuropathic pain
@en
Inhibition of spinal microglial cathepsin S for the reversal of neuropathic pain
@nl
prefLabel
Inhibition of spinal microglial cathepsin S for the reversal of neuropathic pain
@ast
Inhibition of spinal microglial cathepsin S for the reversal of neuropathic pain
@en
Inhibition of spinal microglial cathepsin S for the reversal of neuropathic pain
@nl
P2093
P2860
P50
P3181
P356
P1476
Inhibition of spinal microglial cathepsin S for the reversal of neuropathic pain
@en
P2093
Amelia A. Staniland
Clive Gentry
Fabien Marchand
Glen Wotherspoon
Jakir Ullah
Janet Winter
John Grist
Maliheh Dehvari
Ping K. Yip
P2860
P304
10655–10660
P3181
P356
10.1073/PNAS.0610811104
P407
P577
2007-06-19T00:00:00Z